Agilent Technologies Inc (A)vsICON PLC (ICLR)
A
Agilent Technologies Inc
$112.98
-1.07%
HEALTHCARE · Cap: $31.96B
ICLR
ICON PLC
$99.99
-1.27%
HEALTHCARE · Cap: $7.88B
Smart Verdict
WallStSmart Research — data-driven comparison
ICON PLC generates 15% more annual revenue ($8.10B vs $7.07B). A leads profitability with a 18.3% profit margin vs 7.4%. A appears more attractively valued with a PEG of 1.19. A earns a higher WallStSmart Score of 61/100 (C+).
A
Buy61
out of 100
Grade: C+
ICLR
Buy53
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-318.5%
Fair Value
$30.80
Current Price
$112.98
$82.18 premium
Margin of Safety
-163.8%
Fair Value
$50.46
Current Price
$99.99
$49.53 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 20 in profit
Strong operational efficiency at 22.9%
Reasonable price relative to book value
Attractively priced relative to earnings
Areas to Watch
Grey zone — moderate risk
Weak financial health signals
Earnings declined 3.6%
0.6% revenue growth
Distress zone — elevated risk
ROE of 6.3% — below average capital efficiency
7.4% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : A
The strongest argument for A centers on Return on Equity, Operating Margin. Profitability is solid with margins at 18.3% and operating margin at 22.9%. PEG of 1.19 suggests the stock is reasonably priced for its growth.
Bull Case : ICLR
The strongest argument for ICLR centers on Price/Book, P/E Ratio.
Bear Case : A
The primary concerns for A are Altman Z-Score, Piotroski F-Score, EPS Growth.
Bear Case : ICLR
The primary concerns for ICLR are Revenue Growth, Altman Z-Score, Return on Equity.
Key Dynamics to Monitor
A profiles as a mature stock while ICLR is a value play — different risk/reward profiles.
ICLR carries more volatility with a beta of 1.34 — expect wider price swings.
A is growing revenue faster at 7.0% — sustainability is the question.
ICLR generates stronger free cash flow (352M), providing more financial flexibility.
Bottom Line
A scores higher overall (61/100 vs 53/100), backed by strong 18.3% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Agilent Technologies Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.
ICON PLC
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
ICON Public Limited Company, a clinical research organization, provides outsourced marketing and development services in Ireland, the rest of Europe, the United States and internationally. The company is headquartered in Dublin, Ireland.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?